Wealth Enhancement Advisory Services LLC Purchases New Stake in Innovator IBD 50 ETF (NYSEARCA:FFTY)

Wealth Enhancement Advisory Services LLC purchased a new stake in Innovator IBD 50 ETF (NYSEARCA:FFTY) during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,161 shares of the company’s stock, valued at approximately $733,000.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Tower Research Capital LLC TRC raised its holdings in Innovator IBD 50 ETF by 47.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 15,225 shares of the company’s stock valued at $435,000 after acquiring an additional 4,883 shares in the last quarter. Raymond James Financial Inc. bought a new stake in shares of Innovator IBD 50 ETF during the 4th quarter valued at about $284,000. Finally, Two Sigma Investments LP bought a new stake in shares of Innovator IBD 50 ETF during the 4th quarter valued at about $1,138,000.

Innovator IBD 50 ETF Stock Up 2.2%

FFTY opened at $32.65 on Friday. The firm has a market cap of $81.63 million, a price-to-earnings ratio of 30.34 and a beta of 1.32. Innovator IBD 50 ETF has a fifty-two week low of $22.91 and a fifty-two week high of $34.26. The company’s 50-day moving average price is $29.76 and its 200 day moving average price is $29.06.

About Innovator IBD 50 ETF

The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.